News

The latest from Orpyx

Orpyx Medical Technologies utilizes the animated infographic approach in their savvy social media campaign to better communicate the dangers of diabetes-related foot complications.

Calgary, AB - June 25, 2012 - Calgary-based medical technology start-up Orpyx is turning traditional healthcare marketing on its head with their new diabetes awareness campaign, Diabetes Can Knock You Off Your Feet. Orpyx's social media friendly initiative uses the growing trend of animated infographics to dynamically communicate their key message.

Orpyx is developing a sensor-based insole that will empower diabetics to play a more active role in the prevention of diabetes-related foot complications. Part of Orpyx's mission is to increase awareness around the importance of prevention relating to diabetic foot care. Over the course of their disease, more than 60% of diabetics will suffer from peripheral nerve damage, or numb feet, caused by their diabetes. This lack of pain feedback can lead to a host of devastating side effects including infections, ulcers and ultimately, amputations. When proper prevention steps are observed, amputations can be reduced by up to 85%.

 

"Our challenge was in finding a way to make the subject matter stick," said Dr. Breanne Everett, CEO of Orpyx Medical Technologies. "Unfortunately, diabetes is being diagnosed more frequently and at a younger age than ever before so we have to shift our communication strategy to effectively speak to this audience. Animated infographics are a visually compelling communication medium that can translate complex data into a visual format that is easy to follow and even easier to share."

 

Diabetes technology is a burgeoning industry, trying to keep up to the staggering increase in annual diagnosis rates. As consumers become more dependent on apps, mobile devices and social media in their personal lives, the move to introduce technology into disease management and prevention seems only natural. Social media isn't a new concept for Orpyx. In just under a year, they have amassed an impressive following of engaged users across popular social media platforms including Twitter, Facebook and Pinterest. Orpyx hopes that its campaign approach will hit home with the increasingly tech-savvy diabetes advocates, influencers and educators. The animated infographic is available to view and share on Orpyx's YouTube Channel, or via their website www.orpyx.com

For more information, please contact:

Amanda Hehr
VP Marketing, Orpyx Medical Technologies Inc.
M (403) 805-6446
O (403) 709-0129
amanda.hehr@orpyx.com

About Orpyx Medical Technologies:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 60-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.

Orpyx was honored with $20k at the TEC Edmonton VenturePrize Awards in the Student Business Plan category. The competition included a gamut of impressive technology start-ups from across the province pitching their concepts to a roomful of technology movers and shakers. 

Calgary, AB - May 7, 2012 - Orpyx Medical Technologies was one of a number of Alberta-based companies competing for cash and in-kind goods and services at the 10th Annual TEC Edmonton VenturePrize Awards in Edmonton last week. TEC VenturePrize is a program of TEC Edmonton, providing training, professional support and financial incentives to help people build or enhance a viable technology-based business. The competition marked the final round of a series of regional business plan competitions held in the months leading up to the VenturePrize event. After winning the Calgary-region Student Technology Innovation Challenge (STIC) in February, Dr. Breanne Everett presented Orpyx’s business plan to a panel of judges in Edmonton. After an amazing evening packed with inspirational speeches and presentations, Orpyx was announced as the winner in their category.

“We are so thrilled and honoured to have been recognized at the VenturePrize Awards, among a truly amazing group of up-and-coming companies,” says Dr. Breanne Everett, CEO and President, Orpyx Medical Technologies. “TEC Edmonton has been such a supportive community—a tremendous asset to an emerging company. It's a very exciting time to be in Alberta and part of the growing innovation scene.”

The other two companies competing in the Student Business Plan finals were CitizenBridge from the University of Lethbridge, and ENERCAL Data Systems from the University of Calgary. Everyone in attendance agreed that without the resources, mentorship and financial support made available through agencies such TEC Edmonton and Innovate Calgary, the viability of tech-based businesses  in Alberta would be substantially compromised. Orpyx plans on applying their VenturePrize Award towards their technology development costs and commercialization goals for late 2012.

For more info, please contact:

Amanda Hehr
VP Marketing, Orpyx Medical Technologies Inc.
M (403) 805-6446
O (403) 709-0129
amanda.hehr@orpyx.com

About Orpyx Medical Technologies Inc.:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by 27-year-old Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user using the ANT+ wireless technology protocol.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.

About TEC Edmonton:

TEC Edmonton helps transform high-tech discoveries into viable business opportunities. Through our business services, TEC Edmonton helps navigate the commercialization process by providing assistance with technology evaluation, intellectual property protection, business plan development, marketing research, corporate management and funding preparation – as well as provides a home for startups in the TEC Centre incubation facility. A unique non-for-profit enterprise, TEC Edmonton is a joint venture between Edmonton Economic Development Corporation (EEDC) and the University of Alberta. For more information visit www.tecedmonton.com.

“In the spirit of ideas worth spreading, TEDx is a program of local, self-organized events that bring people together to share a TEDlikeexperience. At a TEDx eventTEDTalks video and live speakers combine to spark deep discussion and connection in a small group. These local, self-organized events are branded TEDx, where x=independently organized TED event. The TED Conference provides general guidance for the TEDx program, but individual TEDx events are self-organized.” Dr. Breanne Everett has been invited to speak as one of TEDxYYC’s keynote speakers at their event on May 25, 2012 at the new Telus Spark. She will be speaking to the topic of medical innovation.

Read about the 2012 TEDxYYC speaker announcement in the Calgary Herald

Inventing the world’s first sensory substitution diabetic shoe insole, 27-year-old Dr. Breanne Everett of Calgary catches the attention of medical professionals, high profile investors and Hollywood filmmakers alike

Calgary, AB - February 12, 2012 - Without a doubt, diabetes is one of the most devastating and not-so-quietly growing epidemics of modern society.  Nearly four times more common than all types of cancer combined, it is fast becoming one of the major public health concerns of the 21st century, ranking as the fifth leading cause of death in the world, with an affected population that has toppled the 350 million mark globally.

Having seen the debilitating and often fatal side effects of the disease firsthand, Calgary surgical resident Dr. Breanne Everett has set out to change the face of diabetes-related complications; her groundbreaking research quickly turning heads in the international medical community and beyond.

One of the most common side effects of both Type I and Type II diabetes is the loss of sensory feedback in an affected person’s feet, rendering them unaware that pressure-inducing damage is being done.  Also known as diabetic peripheral neuropathy, the results can be catastrophic, progressing from numbness and tissue damage to ulceration and foot and leg amputation.

Equated to dental freezing that leaves one highly susceptible to inflicting unintentional injury on a frozen cheek or lip, half of all Type I and II diabetics will develop peripheral neuropathy, with half of those developing serious tissue breakdown, ulceration and infection. 

In an effort to develop a product that would enable this growing global population to regain lost sensory feedback in their feet – some sort of ‘hint’ that they are doing potentially life-threatening damage, 27-year-old Breanne has put her Plastic and Reconstructive Surgery residency at the University of Calgary on hold to pioneer the world’s first diabetic sensory substitution shoe insole.

Diving headlong into research around sensory substitution systems, the Calgary native quickly realized the key was to tap into the human brain’s propensity for ‘plasticity,’ or, its phenomenal ability to rewire itself.  The goal was to transfer the feeling of walking, stepping and jumping to register somewhere else on the body.

With the support of the U of C Department of Surgery and the global diabetic foot community, a board of directors that reads like a who’s-who of the North American medical technology realm and a handful of high profile investors, engineers, doctors and plastic surgeons, Breanne now serves as president and CEO of Orpyx Medical Technologies – the company behind two game-changing innovations:  the SurroSense Rx and the SurroGait Rx.

Orpyx’s flagship product is the SurroSense Rx – a state-of-the-art, pressure-sensing shoe insole designed and engineered specifically with the diabetic in mind.  The insole takes information from the patient’s movements and, with the help of ANT+ wireless technology, transmits it to an ergonomic wristband display, thereby informing the user when damage is being done to the feet so that behaviours can be altered and devastating complications avoided.

 

The company’s second and equally revolutionary product is the SurroGait Rx – a pressure-sensing insole that provides substitute sensation for numb feet and enables the user to miraculously regain feeling and awareness, thanks to the insole’s ability to wirelessly transmit pressure data to a stimulus pad worn on the lower back.  The patient is left with the sensation that they are literally ‘walking’ on their back, and able to adjust their gait as necessary to avoid injury and increase balance and mobility.

Beyond diabetes, peripheral neuropathy or lost sensation in the feet can develop as a result of everything from stroke to drug side effects and vitamin deficiencies, making the potential for Orpyx’s innovative technologies endlessly applicable, while deinstitutionalizing an affected person’s rehabilitation work, affordably allowing them to take control of their own health and play an active role in their disease reversal and recovery.

As the products undergo ongoing clinical trials in both the U.S. and Canada, new investors come to the table and enthusiastic attention is cast on Orpyx’s work, the commercialization of the devices becomes closer than ever, with the SurroSense Rx slated to hit the market in Nov. 2012.  The SurroGait Rx is expected to follow with worldwide retail availability towards the end of 2013.

As for Breanne’s accolades so far, which include her recent honouring with the A100’s prestigious ‘One to Watch’ Award, a cameo in the upcoming U.S. film The Diabetic You, a request to serve as one of TEDxYYC’s primary keynote presenters in 2012 and numerous invitations to attend medical and technology conferences worldwide, it’s clear there’s nowhere to go but up for this incredible Calgary start-up, boldly spearheaded by one of Canada’s brightest young minds. 

"We believe that with our innovative research and groundbreaking technologies, Orpyx’s devices will change diabetic footcare from the reactionary practice it is today to a highly dynamic, preventative discipline. It’s time to stop being afraid, and time to start living."
– Dr. Breanne Everett, president and CEO, Orpyx Medical Technologies Inc.

For more info, please contact:

Amanda Hehr
VP Marketing, Orpyx Medical Technologies Inc.
M (403) 805-6446
O (403) 709-0129
amanda.hehr@orpyx.com

About Orpyx Medical Technologies Inc.:

Orpyx was created out of a profound desire to address the swiftly-growing global diabetes epidemic and its related complications, notably that of diabetic peripheral neuropathy – loss of feeling and sensory feedback in the feet experienced by an estimated 50-percent of the 350 million diabetics worldwide, that can lead to tissue damage, infection, ulceration and amputation.

Founded by 27-year-old Calgary surgical resident Dr. Breanne Everett, Orpyx is behind two highly innovative plantar sensory replacement systems, the SurroSense Rx and the SurroGait Rx, that use pressure sensor-embedded shoe insoles to determine force exerted over the bottom of the feet, and wirelessly transmit collected information to a back pad, mobile device or wristwatch worn by the user using the ANT+ wireless technology protocol.  Employing the phenomenon of neuroplasticity – the potential of the human brain to rewire itself, the patient is able to interpret the sensory stimulus felt on the back as that from the feet, and positively adjust their gait, balance, mobility and overall health as a result.